We Think Lexaria Bioscience (NASDAQ:LEXX) Needs To Drive Business Growth Carefully
So, the natural question for Lexaria Bioscience (NASDAQ:LEXX) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...
HighTower Advisors LLC Grows Position in Lexaria Bioscience Corp. (NASDAQ:LEXX)
HighTower Advisors LLC boosted its holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 61.4% in the fourth ...
Lexaria Bioscience provides update on ongoing human study GLP-1-H24-4
Lexaria Bioscience (LEXX) provided a progress update on its Phase 1b, 12-week chronic study GLP-1-H24-4 underway in Australia. Enrollment of ...
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
Lexaria Bioscience begins dosing for GLP-1 study #5
Lexaria Bioscience (LEXX) announced that dosing has begun as scheduled in its human study GLP-1-H25-5 that is comparing oral ...
Lexaria's Human GLP-1 Study #5 Begins Dosing
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
14-year-old Lexx to cycle 1,000 miles for dyslexia awareness
A 14-year-old boy is set to cycle 1,000 miles for dyslexia awareness. Lexx, who is part of a group of 12 neurodiverse children, will ride from John O'Groats to Land's End. Despite travelling 80 miles ...
Wall Street Journal23d
Lexaria Bioscience Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...